How2Exit

MARCH 17, 2023

He quickly grew his business to $36 million in sales in 2016, and was able to sell a piece of technology he had developed to a shopping cart. Nate was able to negotiate a deal that was ten times the cost of his parent’s home, which was a huge success. This was his first experience in selling a business and it was a huge success.

Broker 130

Broker Business Sale IT 130

InvestmentBank.com

OCTOBER 24, 2019

M&A activity in physician practices continues to grow and outpace other sectors as deals in the healthcare industry are coveted by investors for their strong growth, recession resistance, and superior historical returns.

Hospitality 40

Hospitality Private Equity Equities Acquisitions 40

Cooley M&A

APRIL 7, 2017

According to a recent study by SRS of recent private life sciences deals, disputes over earn-outs arose in about one-third (36%) of all milestones that were expected to be hit by September 2016. [1] for a Hematologic Cancer Indication.”

Mergers and Acquisitions 40

Mergers and Acquisitions Negotiation Pharmaceutical IT 40

Peak Frameworks

SEPTEMBER 12, 2023

For instance, consider Tesla's acquisition of SolarCity in 2016. Investment Bankers M&A advisory is replete with examples of retainer fees. Investment Bankers M&A advisory is replete with examples of retainer fees. A retainer fee is money paid to ensure that a professional will provide services to you.

Finance 52

Finance Finance Mergers and Acquisitions Private Equity 52

Cooley M&A

DECEMBER 3, 2019

Aon estimates that over 45% of all private M&A transactions in North America had R&W insurance in 2018. [2]. From 2008 to 2018, the total R&W policies bound per year in North America rose from 40 deals, providing $541 million of coverage to 1500+ R&W insurance transactions, providing aggregate coverage of $38.6 Advantages.

Insurance 40

Insurance Underwriting Mergers and Acquisitions M&A 40

Cooley M&A

OCTOBER 29, 2018

M&A practitioners have long advised boards of directors that the Delaware courts have never found that the events or circumstances in a particular transaction met the contractual standard of having a material adverse effect (or MAE) as defined in a merger or acquisition agreement. We can no longer give this advice. 2018-0300-JTL (Del.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Business Pharmaceutical 52

Cooley M&A

MAY 17, 2017

See our December 2016 client alert. thus far in 2017 and a few directors (four in 2016) failed to earn majority support. thus far in 2017 and a few directors (four in 2016) failed to earn majority support. It is too soon to assess the impact that negative recommendations this proxy season may have on director elections.

IPO 52

IPO Government Advisory Corporation 52

Cooley M&A

JANUARY 20, 2022

General trends in life sciences M&A. While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. driven assets.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JULY 9, 2021

In a string of seminal decisions from 2017 through 2019 ( DFC Global , Dell and Aruba ), the Delaware Supreme Court re-shaped appraisal jurisprudence, in each case by overturning the Court of Chancery for failing to give adequate weight to deal price as the most reliable indicator of fair value. share, a 2.67% increase over the deal price.

Mergers and Acquisitions 52

Mergers and Acquisitions Sale Shares Entertainment 52

Cooley M&A

SEPTEMBER 13, 2017

Sometimes, however, parties to M&A transactions attempt to circumvent California’s hostility to post-employment non-compete covenants by entering into such restrictive covenants with sellers who are also employees of the selling entity. Yann Boulbain was VP of global sales at Ergo until his employment terminated in late 2016.

M&A 52

M&A IT Government Negotiation 52

Cooley M&A

FEBRUARY 22, 2017

So far this year, deal parties are approaching M&A with cautious optimism. This series of Cooley M&A blog posts include some brief observations that offer some M&A highlights over the past year and our thoughts for the year to come. Delaware Confronts M&A Litigation. KKR Financial Holdings (Del.

M&A 40

M&A Insurance Negotiation Corporation 40

Cooley M&A

FEBRUARY 24, 2017

So far this year, deal parties are approaching M&A with cautious optimism. This series of Cooley M&A blog posts include some brief observations that offer some M&A highlights over the past year and our thoughts for the year to come. Negotiating Anti-Reliance Language. Innovation Pressures Fuel M&A.

Negotiation 40

Negotiation M&A Insurance Acquisitions 40

Cooley M&A

FEBRUARY 15, 2017

So far this year, deal parties are approaching M&A with cautious optimism. Over the next few days, we will run a series of Cooley M&A blog posts with some brief observations that offer some M&A highlights over the past year and our thoughts for the year to come. Read more from our 2017 M&A Trends Series.

M&A 40

M&A IPO Pharmaceutical Valuation 40

Cooley M&A

FEBRUARY 17, 2017

So far this year, deal parties are approaching M&A with cautious optimism. This series of Cooley M&A blog posts include some brief observations that offer some M&A highlights over the past year and our thoughts for the year to come. Innovation Pressures Fuel M&A. Delaware Confronts M&A Litigation.

M&A 40

M&A Equities Acquisitions Management 40

Cooley M&A

FEBRUARY 23, 2017

So far this year, deal parties are approaching M&A with cautious optimism. This series of Cooley M&A blog posts include some brief observations that offer some M&A highlights over the past year and our thoughts for the year to come. Read more from our 2017 M&A Trends Series. Appraisal Risks Factor High.

M&A 40

M&A Mergers and Acquisitions Insurance Stock 40

Cooley M&A

JANUARY 18, 2017

The Obama Administration went out with a bang in 2016 on the merger enforcement front in potential reaction to criticism from the left that previous enforcement had been lax. Transition to a Trump Administration is top of the agenda. Uncertainty over how vigorous merger enforcement will be in the Trump Administration. Penn State Hershey.

Mergers and Acquisitions 40

Mergers and Acquisitions Pharmaceutical Mergers Investment 40